Robert Driscoll
Stock Analyst at Wedbush
(4.48)
# 1,078
Out of 4,468 analysts
347
Total ratings
45.9%
Success rate
11.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Robert Driscoll
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| REPL Replimune Group | Reiterated: Hold | $6 → $9 | $11.58 | -22.28% | 18 | Jun 30, 2026 | |
| TYRA Tyra Biosciences | Reiterated: Buy | $53 | $30.62 | +73.09% | 15 | Jun 16, 2026 | |
| KURA Kura Oncology | Reiterated: Buy | $36 | $11.10 | +224.32% | 30 | Jun 15, 2026 | |
| IDYA IDEAYA Biosciences | Reiterated: Buy | $58 | $37.65 | +54.05% | 25 | Jun 12, 2026 | |
| CGEM Cullinan Therapeutics | Maintained: Buy | $37 | $17.63 | +109.87% | 18 | Jun 11, 2026 | |
| CTMX CytomX Therapeutics | Reiterated: Buy | $11 | $3.82 | +187.96% | 18 | Jun 4, 2026 | |
| CBIO Crescent Biopharma | Maintained: Buy | $27 | $17.09 | +57.99% | 5 | Jun 1, 2026 | |
| BDTX Black Diamond Therapeutics | Maintained: Buy | $14 | $2.01 | +596.52% | 14 | Jun 1, 2026 | |
| RVMD Revolution Medicines | Reiterated: Buy | $165 | $189.24 | -12.81% | 23 | Jun 1, 2026 | |
| CRBP Corbus Pharmaceuticals Holdings | Reiterated: Buy | $38 → $30 | $9.25 | +224.32% | 6 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $2.63 | +128.14% | 2 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $70.36 | +13.70% | 4 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 → $34 | $18.84 | +80.47% | 4 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $6 | $0.741 | +709.72% | 8 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 → $33 | $29.46 | +12.02% | 11 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $11 | $8.39 | +31.11% | 26 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $7 → $5 | $12.54 | -60.13% | 3 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $5.30 | +88.68% | 14 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $76 → $36 | $15.54 | +131.66% | 10 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37 | $24.21 | +52.83% | 10 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $41 | $30.33 | +35.18% | 23 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 → $25 | $9.00 | +177.78% | 9 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $6 → $1 | $0.3404 | +193.77% | 4 | Dec 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 | $4.46 | -10.31% | 13 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $27 | $7.34 | +267.85% | 1 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 → $6 | $1.36 | n/a | 14 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $2.27 | n/a | 4 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $67 | $131.27 | n/a | 1 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 → $6 | $4.87 | n/a | 8 | Mar 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $15.23 | n/a | 4 | Oct 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $7 → $10 | $0.0001 | n/a | 2 | Mar 19, 2020 |
Replimune Group
Jun 30, 2026
Reiterated: Hold
Price Target: $6 → $9
Current: $11.58
Upside: -22.28%
Tyra Biosciences
Jun 16, 2026
Reiterated: Buy
Price Target: $53
Current: $30.62
Upside: +73.09%
Kura Oncology
Jun 15, 2026
Reiterated: Buy
Price Target: $36
Current: $11.10
Upside: +224.32%
IDEAYA Biosciences
Jun 12, 2026
Reiterated: Buy
Price Target: $58
Current: $37.65
Upside: +54.05%
Cullinan Therapeutics
Jun 11, 2026
Maintained: Buy
Price Target: $37
Current: $17.63
Upside: +109.87%
CytomX Therapeutics
Jun 4, 2026
Reiterated: Buy
Price Target: $11
Current: $3.82
Upside: +187.96%
Crescent Biopharma
Jun 1, 2026
Maintained: Buy
Price Target: $27
Current: $17.09
Upside: +57.99%
Black Diamond Therapeutics
Jun 1, 2026
Maintained: Buy
Price Target: $14
Current: $2.01
Upside: +596.52%
Revolution Medicines
Jun 1, 2026
Reiterated: Buy
Price Target: $165
Current: $189.24
Upside: -12.81%
Corbus Pharmaceuticals Holdings
May 27, 2026
Reiterated: Buy
Price Target: $38 → $30
Current: $9.25
Upside: +224.32%
May 18, 2026
Reiterated: Buy
Price Target: $6
Current: $2.63
Upside: +128.14%
May 18, 2026
Reiterated: Buy
Price Target: $80
Current: $70.36
Upside: +13.70%
May 14, 2026
Reiterated: Buy
Price Target: $29 → $34
Current: $18.84
Upside: +80.47%
May 14, 2026
Reiterated: Buy
Price Target: $7 → $6
Current: $0.741
Upside: +709.72%
May 14, 2026
Reiterated: Buy
Price Target: $19 → $33
Current: $29.46
Upside: +12.02%
May 13, 2026
Maintained: Hold
Price Target: $11
Current: $8.39
Upside: +31.11%
May 12, 2026
Maintained: Sell
Price Target: $7 → $5
Current: $12.54
Upside: -60.13%
May 8, 2026
Reiterated: Buy
Price Target: $10
Current: $5.30
Upside: +88.68%
May 8, 2026
Reiterated: Buy
Price Target: $76 → $36
Current: $15.54
Upside: +131.66%
May 8, 2026
Maintained: Buy
Price Target: $37
Current: $24.21
Upside: +52.83%
Apr 22, 2026
Reiterated: Buy
Price Target: $41
Current: $30.33
Upside: +35.18%
Mar 13, 2026
Reiterated: Buy
Price Target: $80 → $25
Current: $9.00
Upside: +177.78%
Dec 19, 2025
Downgraded: Hold
Price Target: $6 → $1
Current: $0.3404
Upside: +193.77%
Aug 7, 2025
Maintained: Hold
Price Target: $4
Current: $4.46
Upside: -10.31%
Jul 14, 2025
Initiated Coverage: Buy
Price Target: $27
Current: $7.34
Upside: +267.85%
May 8, 2025
Maintained: Buy
Price Target: $7 → $6
Current: $1.36
Upside: n/a
Aug 14, 2024
Reiterated: Buy
Price Target: $8
Current: $2.27
Upside: n/a
Nov 19, 2021
Maintained: Buy
Price Target: $67
Current: $131.27
Upside: n/a
Mar 8, 2021
Maintained: Buy
Price Target: $7 → $6
Current: $4.87
Upside: n/a
Oct 5, 2020
Maintained: Buy
Price Target: $8
Current: $15.23
Upside: n/a
Mar 19, 2020
Downgraded: Hold
Price Target: $7 → $10
Current: $0.0001
Upside: n/a